Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2026-05-05 @ 9:29 PM
Study NCT ID:
NCT02665650
Status:
COMPLETED
Last Update Posted:
2019-05-16
First Post:
2016-01-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Sponsor:
Organization: